Treating IgA Nephropathy

Treating IgA nephropathy.

IgA nephropathy may be the most common type of glomerulonephritis, worldwide. Once thought benign, it causes endstage renal disease in 15 to 20% of individuals within 10 yr of onset (1) and in 30 to 35% of individuals within 20 yr of onset. Proteinuria, an elevated serum creatinine concentration, and hypertension predict progression (1) as does a renal biopsy demonstrating focal proliferative g...

IgA nephropathy.

A great interest in IgA nephropathy was demonstrated in the last few years. Unfortunately, a complete picture of this chronic disease should not yet been made. The article deals with 7 patients with IgA nephropathy treated in our Institute. The following characteristics were examined during a long period of time (1-17 years): clinical picture, course of the disease, clinical and morphologic cor...

[IgA nephropathy].

IgA nephropathy is glomerular disease first described in 1968 by Berger, named after him Morbus Berger. The disease is characterized by the presence of IgA dominant or codominant immunoglobulin deposits in glomerular mesangium which can be demonstrated by immunofluorescence. Clinical manifestations of IgA nephropathy in the majority of cases is hematuria which can be macro or microscopic, isola...

IgA Nephropathy.

IgA nephropathy (IgAN) is a leading cause of CKD and renal failure. Recent international collaborative efforts have led to important discoveries that have improved our understanding of some of the key steps involved in the immunopathogenesis of IgAN. Furthermore, establishment of multicenter networks has contributed to rigorous design and execution of clinical trials that have provided importan...

IgA nephropathy.